Research study Program year 2025 Source: CMS Open Payments

Two Arm Randomized Phase 3 Study in High Risk Nsclc Comparing Canakinumab VS Placebo in Adjuvant Setting

Research payments

$5,410,989

292 payments

Through program year 2025, $5,410,989 in research payments was reported against Two Arm Randomized Phase 3 Study in High Risk Nsclc Comparing Canakinumab VS Placebo in Adjuvant Setting, across 292 payments, paid by Novartis Pharmaceuticals Corporation.

Paid by
Novartis Pharmaceuticals Corporation
ClinicalTrials.gov
No trial number was reported for this study

By program year

7 rows
Year Kind Amount Payments
2025 Research $4,376 2
2024 Research $15,653 15
2023 Research $618,973 57
2022 Research $1,164,624 50
2021 Research $1,529,270 57
2020 Research $1,242,023 60
2019 Research $836,070 51

Breakdown

Who paid Research payments · program years 2019–2025
  1. Novartis Pharmaceuticals Corporation $5,410,989 292 payments
Who received the money Research payments · program years 2019–2025
  1. Sarah Cannon Research Institute Organisation paid for research $1,386,317 24 payments
  2. US Oncology Research Organisation paid for research $767,790 10 payments
  3. Virginia Cancer Specialists Organisation paid for research $370,790 5 payments
  4. Fort Wayne Medical Oncology Hematology Organisation paid for research $210,843 4 payments
  5. Translational Research In Oncology INC Organisation paid for research $208,335 4 payments
  6. Texas Oncology PA Organisation paid for research $195,447 1 payment
  7. Ronald Reagan Ucla Teaching hospital · CA $192,563 5 payments
  8. Cleveland Va Medical Research And Education Foundation Organisation paid for research $185,842 4 payments
  9. Florida Cancer Specialists And Research Institute Organisation paid for research $178,260 10 payments
  10. Tennessee Oncology Organisation paid for research $162,106 2 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record